BIOSCIENCE BIOTECHNOLOGY RESEARCH COMMUNICATIONS DIABETIC PREDECESSORS: A FACTOR LEADING TO DIABETES IN SUCCESSORS 713
Manju Dewan
the large human brain rather than to the insulin-sensi-
tive muscle mass. Measuring these phenomena early in
life rather than in adulthood may more closely re ect
their evolutionary tendencies. In addition, the life span
of early humans was limited and evolution has there-
fore mostly worked on the physiology of young people
(Boyd-Eaton et al 1988and Ritenbaugh,1989)
The study of young individuals meets the goals of
predictive genetic epidemiology because it allows the
follow-up of genotyped patients through later pheno-
type evolution as well as clinical trials (Le Stunff et al,
2001). It has recently been put forward that several fat-
derived cytokines, including the anti-in ammatory adi-
ponectin, strongly modulate the risk of the metabolic
syndrome and T2D associated with obesity (diabesity)
(Lazar, 2006). Variation within the adiponectin gene is
reported to modulate plasma levels of adiponectin and
also to predict risk for diabesity and associated coronary
heart diseases (Vasseur et al, 2003). Paradoxically, the
adiponectin variant alleles that protect against the devel-
opment of diabesity by maintaining high adiponectin
concentrations also associate with obesity risk in both
adults and obese children (Bouatia-Naji et al, 2003).
Individuals with high adiponectin levels can be severely
obese but seem to enjoy metabolic protection (Vasseur
et al, 2005). In the general population, the same alleles,
together with the type 2 diabetes protective PPAR-g
12Ala allele associates with a coronary heart disease
protective risk factor pattern, elevated adiponectin and
insulin sensitivity but also with a dramatic increase of
3 units of body mass index (Tanko et al, 2005).
People having a close relative with type 2 diabetes
are at higher risk. There is also a strong inheritable
genetic connection in type 2 diabetes: having relatives
(especially rst degree) with type 2 increases risks of
developing this disease very substantially. In addition,
there is also a mutation to the Islet Amyloid Polypep-
tide gene that results in an earlier onset, more severe,
form of diabetes (Sakagashira, 1996). Developing type 2
diabetes is heavily in uenced by environmental factors.
Since our genetic code does not change signi cantly in
one or two generations, the recent secular trend in dia-
betes must be due mostly to changes in the environment.
Increased adiposity is the single most signi cant factor
in the development of type 2 diabetes and the epidem-
ics of obesity and type 2 diabetes largely parallel one
another. The increasing prevalence of obesity is thought
to be related primarily to changes in dietary habits and
our increasingly sedentary lifestyle, though other factors
(including toxins and infectious agents) may play a role.
Genes may in uence the risk of diabetes not only by
directly altering insulin action or secretion, but also by
altering how any given individual interacts with these
environmental factors (Cho et al 2003).
However, environmental factors (almost certainly diet
and weight) play a large part in the development of type
2 diabetes in addition to any genetic component. This
can be seen from the adoption of the type 2 diabetes
epidemiological pattern in those who have moved to a
different environment as compared to the same genetic
pool (Cotran and Collins, 1999).There is a stronger
inheritance pattern for type2 diabetes. Those with rst-
degree relatives with type2 diabetes have a much higher
risk of developing type2 diabetes, increasing with the
number of those relatives. Concordance among monozy-
gotic twins is close to 100%, and about 25% of those
with the disease have a family history of diabetes. Genes
signi cantly associated with developing type2 diabetes,
include TCF7L2, PPARG, FTO, KCNJ11, NOTCH2, WFS1,
CDKAL1, IGF2BP2, SLC30A8, JAZF1, and HHEX (Lys-
senkoet al, 2008). KCNJ11 (potassium inwardly rectify-
ing channel, subfamily J, member 11), encodes the islet
ATP-sensitive potassium channel Kir6.2, and TCF7L2
(transcription factor 7–like 2) regulates proglucagon
gene expression and thus the production of glucagon-
like peptide-1 (Rother et al, 2007). Moreover, obesity
(which is an independent risk factor for type2 diabetes)
is strongly inherited (National Diabetes Information-
Clearinghouse (NDIC), 2008).
Various hereditary conditions may feature diabe-
tes, for example myotonic dystrophy and Friedreich’s
Ataxia. Wolfram’s syndrome is an autosomal recessive
neurodegenerative disorder that rst becomes evident
in childhood. It consists of diabetes insipidus, diabetes
mellitus, optic atrophy and deafness, hence the acronym
DIDMOAD (Barrett 2001). A major risk factor of type 2
diabetes mellitus (T2DM) is a positive family history of
diabetes. In the present study it was found that family
historyofobesitywasmorelikelytohavemorepreva-
lence ofobesityandoverweightthanthosehavingfam-
ilyhistoryofdiabetes.Thisindicatesthatchildrenhav-
ing family history of obesity are more likely to
become obese or over weight and diabetes.In the pre-
sent study, subject having impaired glucose levels and
diabetes have the positive family history in rst degree
relatives 4.3% subjects have the 1st degree relatives in
having impaired glucose level and diabetes. Children
with type 2 diabetes usually have a family history of
this disease. Of the patients, 74–100% have a rst- or
second-degree relative with type 2 diabetes (American
Diabetes Association, 2000 and Arslanian, 2002). Of
note, diabetes in the parent or other relative may not
be recognized until the child is diagnosed. The high fre-
quency of relatives with type 2 diabetes demonstrate the
strong hereditary (likely multigenic) component to the
disease (Kiess et al, 2003).
Papaza ropoulou et al, (2017) suggested that the
likelihood of type 2 diabetes in the next generation is